Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where B. Amichai is active.

Publication


Featured researches published by B. Amichai.


Journal of The European Academy of Dermatology and Venereology | 2010

Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults

Anna Lyakhovitsky; Aviv Barzilai; R Heyman; Sharon Baum; B. Amichai; Michal Solomon; D Shpiro; H Trau

Background  Atopic dermatitis (AD) is a common inflammatory skin disease. Methotrexate (MTX) was suggested as an effective treatment option in cases of moderate‐to‐severe atopic dermatitis. This study assessed the efficacy and safety of treatment with low weekly doses of methotrexate for moderate‐to‐severe AD in adults.


British Journal of Dermatology | 2010

Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study

B. Amichai; B. Nitzan; R. Mosckovitz; Avner Shemer

Background  Onychomycosis is a common disease; topical treatment is usually poorly effective, while systemic treatment is more effective but may be associated with side‐effects. Iontophoretic drug delivery may improve drug penetration through the nail and lead to better therapeutic results.


British Journal of Dermatology | 2009

New criteria for the laboratory diagnosis of nondermatophyte moulds in onychomycosis

Avner Shemer; Batya Davidovici; Marcelo H. Grunwald; H Trau; B. Amichai

Background  Nondermatophyte moulds (NDM) may be found as aetiological agents or as contaminants in onychomycosis. The classic and most used criteria for the diagnosis of NDM are those established by English in 1976.


Journal of Dermatology | 2009

Comparative study of nail sampling techniques in onychomycosis.

Avner Shemer; Batya Davidovici; Marcelo H. Grunwald; Henri Trau; B. Amichai

Onychomycosis is a common problem. Obtaining accurate laboratory test results before treatment is important in clinical practice. The purpose of this study was to compare results of curettage and drilling techniques of nail sampling in the diagnosis of onychomycosis, and to establish the best technique and location of sampling. We evaluated 60 patients suffering from distal and lateral subungual onychomycosis and lateral subungual onychomycosis using curettage and vertical and horizontal drilling sampling techniques from three different sites of the infected nail. KOH examination and fungal culture were used for detection and identification of fungal infection. At each sample site, the horizontal drilling technique has a better culture sensitivity than curettage. Trichophyton rubrum was by far the most common pathogen detected by both techniques from all sampling sites. The drilling technique was found to be statistically better than curettage at each site of sampling, furthermore vertical drilling from the proximal part of the affected nail was found to be the best procedure for nail sampling. With each technique we found that the culture sensitivity improved as the location of the sample was more proximal. More types of pathogens were detected in samples taken by both methods from proximal parts of the affected nails.


Clinical and Experimental Dermatology | 2011

A rationale for systemic treatment in onychomycosis with negative results on fungal examination.

B. Amichai; Batya Davidovici; H Trau; Anna Lyakhovitsky; Marcelo H. Grunwald; Avner Shemer

Background.  Fungal infection of the nail affects millions of people worldwide, and has an estimated prevalence of about 10% of the general population. Laboratory confirmation of fungal infection is currently accepted as a requirement before initiation of antifungal treatment in clinical practice.


Journal of Dermatology | 2010

Ciclopirox nail lacquer for the treatment of onychomycosis : An open non-comparative study

Avner Shemer; Nir Nathansohn; Henri Trau; B. Amichai; Marcelo H. Grunwald

Onychomycosis is a relatively common disease accounting for up to 50% of all nail disorders. Topical treatment, although less effective than systemic, is usually preferred by patients. Topical antifungal nail lacquers have been formulated to provide better delivery of the antifungal agent to the nail unit. The purpose of this research is to evaluate the efficacy and safety of ciclopirox nail lacquer in the treatment of onychomycosis. Patients suffering from distal and lateral subungual toenail onychomycosis (DLSO) and lateral subungual onychomycosis (LSO) were treated by ciclopirox nail lacquer once daily for 9 months. Every week the nail lacquer was removed using acetone. Clinical nail status, KOH examination and mycological culture were recorded by the same investigator at 0, 3, 6 and 9 months. Thirty‐six patients completed the 9‐month regimen. Trichophyton rubrum was the most common pathogen. At the end of the study, good improvement to complete cure was observed in 13 patients (36%), 12 patients showed only mild to moderate improvement and 11 patients (31%) had no clinical improvement. No adverse effects were noted throughout the treatment period. Ciclopirox nail lacquer seems to be slightly more effective than other topical modalities and could be used in patients who cannot or do not want systemic treatment.


Mycoses | 2009

Onychomycosis in psoriatic patients – rationalization of systemic treatment

Avner Shemer; Henri Trau; Batya Davidovici; Marcelo H. Grunwald; B. Amichai

Nail changes in patients with psoriasis have been reported with varying prevalence. Onychomycosis has been reported in up to 47% of the psoriasis patients. The purpose of this study was to determine the prevalence of nail abnormalities, onychomycosis in psoriasis and response to itraconazole treatment. We evaluated 312 patients suffering from psoriasis for nail changes and onychomycosis. Patients having laboratory confirmation of onychomycosis were treated with three courses of itraconazole (400 mg day−1 for 1 week). Of 312 patients with psoriasis, 67 (21.5%) patients had nail changes, 23 (34%) of them suffered from onychomycosis. Complete cure (clinical and mycological) was achieved in 30% of the patients with onychomycosis. The response to treatment of onychomycosis with itraconazole in psoriasis patients was found to be lower than in the general population. Considering the low response to onychomycosis systemic therapy in psoriatic patients and the potential side‐effects of the treatment, the rationality of this treatment is questionable.


Journal of The European Academy of Dermatology and Venereology | 2008

Onycomycosis due to artificial nails

Avner Shemer; H Trau; Batya Davidovici; Marcelo H. Grunwald; B. Amichai

Background  The use of artificial nails (ANs) as part of nail‐care cosmetics is very popular. Several side effects and complications, such as contact dermatitis and bacterial and fungal infections, have been reported in patients using ANs.


British Journal of Dermatology | 2016

Darier disease in israel: combined evaluation of genetic and neuropsychiatric aspects

R.P. Dodiuk-Gad; E. Cohen-Barak; M. Khayat; H. Milo; L. Amariglio-Diskin; N. Danial-Faran; M. Sah; M. Ziv; A. Shani-Adir; B. Amichai; Abraham Zlotogorski; Z. Borochowitz; D. Rozenman; Stavit A. Shalev

Darier disease (DD) is a rare genodermatosis caused by heterozygous mutations in the ATP2A2 gene. It has been associated with neuropsychiatric manifestations.


Clinical and Experimental Dermatology | 2009

Pancreatic panniculitis and carcinoma of the pancreas

L. Sagi; B. Amichai; A. Barzilai; R. Weitzen; H Trau

Pancreatic panniculitis is a rare complication of carcinoma of the pancreas, most often accompanying the rare acinar cystadenocarcinoma. It presents with painful erythematous subcutaneous nodules typically located on the leg. We present a case of a 79‐year‐old man with neuroendocrine carcinoma of the pancreas and liver metastasis, who developed painful subcutaneous nodules on his shins. Laboratory values included a raised lipase level with normal amylase level and peripheral eosinophilia. The patient was treated with nonsteroidal anti‐inflammatory drugs, dexamethasone and antibiotics, with resolution of the dermatological symptoms.

Collaboration


Dive into the B. Amichai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marcelo H. Grunwald

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H Trau

Sheba Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Abraham Zlotogorski

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

E. Cohen-Barak

Rappaport Faculty of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Shani-Adir

Rappaport Faculty of Medicine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge